Vaccine Asia Live: Forging Strategic Partnership for R&D to Meet High Demands for Vaccines in Asia

As a unique feature of Terrapinn conferences, the roundtable discussions serve as an interactive platform for meaningful discussion. At World Vaccine Congress Asia 2014, Do Tuan Dat, President & General Director of Vabiotech, Vietnam, moderated the discussion on the topic of “Forging Strategic Partnership for R&D to Meet High Demands for Vaccines in Asia”. A consensus was reached among the …

Sinovac Receives Notification of China Government Grant for EV71 Vaccine Project

RMB 60 Million Free Grant for Construction of Dedicated Production Facility  April 24, 2014 Sinovac Biotech Ltd., a leading China-based vaccine manufacturer, announced today that it has received notification that a RMB 60 million free government grant has been approved by China’s Ministry of Finance, National Development and Reform Commission, Ministry of Industry and Information Technology, and National Health and Family Planning Commission for …

Sinovac files new drug application for hand, foot and mouth EV71 vaccine

Sinovac Biotech announced that the new drug application (NDA) for its ED71 vaccine has been filed and accepted by the Beijing Drug Administration. The Beijing Drug Administration will now conduct an on-side inspection of Sinovac's clinical trials and submit their opinion to the Centers for Drug Evaluation (CDE) of China Food and Drug Administration (CFDA) for further review and evaluation. …

Presentation Download: Developing the second generation of enterovirus vaccines against HFMD

HFMD has always been a prevalent problem in Singapore and throughout the rest of Asia. Dr. Shuo Shen, the Chief Scientific Officer, Wuhan Institute of Biological Products of China National Biotec Group spoke at World Vaccine Congress Asia last June on developing the second generation of enterovirus vaccines against HFMD. He drew attention to the outbreak of HFMD in China …